Santiago J A, Garrison E A, Kadowitz P J
Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112.
Eur J Pharmacol. 1994 Mar 21;254(3):207-12. doi: 10.1016/0014-2999(94)90456-1.
N omega-Nitro-L-arginine methyl ester has been reported to have muscarinic receptor blocking activity whereas the nonesterified analog does not bind to muscarinic receptors. The present study was, therefore, undertaken to compare the inhibitory effects of N omega-nitro-L-arginine methyl ester with those of N omega-nitro-L-arginine on baseline tone and on vasodilator responses to acetylcholine, bradykinin, and substance P in the mesenteric vascular bed of the cat under constant flow conditions. Administration of N omega-nitro-L-arginine methyl ester and N omega-nitro-L-arginine in doses of 100 mg/kg i.v. increased baseline tone in the mesenteric vascular bed and inhibited mesenteric vasodilator responses to acetylcholine, bradykinin, and substance P. The increase in mesenteric arterial perfusion pressure and the decrease in vasodilator responses to the three endothelium-dependent vasodilator agents following administration of N omega-nitro-L-arginine methyl ester and N omega-nitro-L-arginine did not differ significantly. The nitric oxide synthase inhibitors did not attenuate vasodilator responses to agents that induce vasodilation by nonendothelium-dependent mechanisms and enhanced responses to the nitrovasodilators. Atropine blocked vasodilator responses to acetylcholine but did not alter responses to bradykinin or substance P. The similarity in the inhibitory effects of N omega-nitro-L-arginine methyl ester and N omega-nitro-L-arginine on responses to acetylcholine, bradykinin, and substance P suggest that the L-arginine analog, N omega-nitro-L-arginine, as well as the methyl ester of N omega-nitro-L-arginine, are useful probes for studying endothelium-dependent vasodilator responses in the mesenteric vascular bed of the cat.
据报道,Nω-硝基-L-精氨酸甲酯具有毒蕈碱受体阻断活性,而未酯化的类似物不与毒蕈碱受体结合。因此,本研究旨在比较在恒流条件下,Nω-硝基-L-精氨酸甲酯与Nω-硝基-L-精氨酸对猫肠系膜血管床的基础张力以及对乙酰胆碱、缓激肽和P物质的血管舒张反应的抑制作用。静脉注射剂量为100mg/kg的Nω-硝基-L-精氨酸甲酯和Nω-硝基-L-精氨酸,可增加肠系膜血管床的基础张力,并抑制肠系膜对乙酰胆碱、缓激肽和P物质的血管舒张反应。注射Nω-硝基-L-精氨酸甲酯和Nω-硝基-L-精氨酸后,肠系膜动脉灌注压的升高以及对三种内皮依赖性血管舒张剂的血管舒张反应的降低并无显著差异。一氧化氮合酶抑制剂并未减弱对通过非内皮依赖性机制诱导血管舒张的药物的血管舒张反应,反而增强了对硝基血管舒张剂的反应。阿托品阻断了对乙酰胆碱的血管舒张反应,但未改变对缓激肽或P物质的反应。Nω-硝基-L-精氨酸甲酯和Nω-硝基-L-精氨酸对乙酰胆碱、缓激肽和P物质反应的抑制作用相似,这表明L-精氨酸类似物Nω-硝基-L-精氨酸以及Nω-硝基-L-精氨酸的甲酯,是研究猫肠系膜血管床内皮依赖性血管舒张反应的有用探针。